Skip to main content
OpenTrials

Clinical trial condition

Thyroid Eye Disease

Explore clinical trials studying Thyroid Eye Disease. Study availability and eligibility vary by location and protocol.

50 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Thyroid Eye Disease trial results

Completed

A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease

NCT06226545

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +15 more
Locations
  • Site 111 Beverly Hills, California, United States
  • Site 105 Palo Alto, California, United States
  • Site 101 San Diego, California, United States
  • Site 103 Miami, Florida, United States
View all 15 locations
View Trial Details
Completed

TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study

NCT05002998

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • The Private Practice of Raymond Douglas, MD - Beverly Hills Beverly Hills, California, United States
  • USC Roski Eye Institute - Los Angeles Los Angeles, California, United States
  • Stanford University Palo Alto, California, United States
  • University of Colorado - Eye Center - PPDS Aurora, Colorado, United States
View all 28 locations
View Trial Details
Completed

Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease

NCT05517421

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Site Number - 1557 Beverly Hills, California, United States
  • Site Number - 1539 Carlsbad, California, United States
  • Site Number - 1502 Los Angeles, California, United States
  • Site Number - 1505 Los Angeles, California, United States
View all 93 locations
View Trial Details
Completed

An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED) (THRIVE-2)

NCT06021054

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Advancing Research International, LLC Los Angeles, California, United States
  • USC Roski Eye Institute Los Angeles, California, United States
  • Amy Patel Jain, MD Newport Beach, California, United States
  • Stanford Byers Eye Institute Palo Alto, California, United States
View all 57 locations
View Trial Details
Completed

A Safety, Tolerability and Efficacy Study of Veligrotug (VRDN 001) in Healthy Volunteers and Participants With Thyroid Eye Disease (TED) ( THRIVE )

NCT05176639

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • University of Colorado - Department of Ophthalmology Aurora, California, United States
  • The Private Office of Raymond Douglas Beverly Hills, California, United States
  • USC Roski Eye Institute Los Angeles, California, United States
  • MACRO Trials, Inc. Los Angeles, California, United States
View all 53 locations
View Trial Details
Completed

Efficacy and Safety of Lonigutamab in Subjects With Thyroid Eye Disease (TED)

NCT05683496

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Clinical Research Site Jacksonville, Florida, United States
  • Clinical Research Site Atlanta, Georgia, United States
  • Clinical Research Site Ann Arbor, Michigan, United States
  • Clinical Research Site East Setauket, New York, United States
View Trial Details
Completed

Study of ZB001 in Chinese Patients With Thyroid Eye Disease

NCT05776121

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Beijing Tongren Hospital, CMU Beijing, China
  • Peking University Third Hospital Beijing, China
  • Third Xiangya Hospital of Central South University Changsha, China
View Trial Details

Related conditions